Effect of Tacrolimus Formulation on Neurological Side Effects in Older Kidney Transplant Recipients
A Pilot Study to Evaluate Impact on Neurological Side Effects (Cognition, Memory, and Tremor) in Elderly (Age>65) Patients
Sponsor: University of California, Davis
This PHASE4 trial investigates Drug Toxicity and Kidney Transplant; Complications and is currently completed. University of California, Davis leads this study, which shows 13 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
May 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — May 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2024 — Jul 2024 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Dec 2022 — Jan 2024 [monthly]
Recruiting PHASE4
▶ Show 8 earlier versions
-
Mar 2022 — Dec 2022 [monthly]
Recruiting PHASE4
-
May 2021 — Mar 2022 [monthly]
Recruiting PHASE4
-
Jan 2021 — May 2021 [monthly]
Recruiting PHASE4
-
Apr 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Apr 2019 — Apr 2020 [monthly]
Recruiting PHASE4
-
Jun 2018 — Apr 2019 [monthly]
Recruiting PHASE4
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Mar 2018 — May 2018 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of California, Davis
- Veloxis Pharmaceuticals
For direct contact, visit the study record on ClinicalTrials.gov .